|Bid||10.31 x 900|
|Ask||10.35 x 900|
|Day's Range||10.09 - 10.60|
|52 Week Range||9.55 - 22.55|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for HLTHLearn more
Koch Industries disclosed big investments in Cue Health, Kore Group Holdings, and blank-check firm Hennessy Capital Investment Corp. VI.
Cue Health Inc. (Nasdaq: HLTH), a mission-driven healthcare technology company, and the National Basketball Association (NBA) today announced that Cue will serve as the league's Official Home and Point of Care Test for the 2021-22 season. The Cue COVID-19 Test for Home and Over The Counter (OTC) Use is the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without physician supervision or a prescription.
Cue Health Inc (NASDAQ: HLTH) will collaborate with Google Cloud to add respiratory viral variant sequencing and tracking to its Cue Integrated Care platform. Cue said it would build Google Cloud's artificial intelligence, machine learning, analytics, and privacy and security tools into its platform, including its Cue Health Monitoring System and rapid molecular COVID-19 test. The COVID-19 test delivers results to mobile devices in approximately 20 minutes. In March, the assay received Emergency